US_Infect_contents.qxp 14/11/07 03:52 Page 2
Contents
WWW
Appears online at www.touchbriefings.com
Advisory Panel
6
Foreword
8
Keith P Klugman, MB, BCh, PhD, FRCPath (Lond) Member-at-Large, Executive Committee,
International Society of Infectious Diseases (ISID)
HIV&AIDS
Beyond the First 25 Years—The International AIDS Society and
Its Role in the Global Response to AIDS 10
Craig McClure Executive Director, International AIDS Society (IAS)
A Promising New Therapy for HIV Infection—Integrase Inhibitor 13
Sidonie A Morrison, PhD
1
and Roy T Steigbigel, MD
2
1. Associate Professor of Medicine and
Pharmacology; 2. Professor of Medicine, Pathology, Microbiology, and Pharmacology, State University of
New York at Stony Brook
Immunosuppressive Effects of Drug Therapies Common in
HIV-infected Patients 17
David J Feola, PharmD, PhD
1
and Alice C Thornton, MD
2
1. Assistant Professor, Department of
Pharmacy Practice and Science, University of Kentucky College of Pharmacy; 2. Associate Professor,
Division of Infectious Diseases, Department of Internal Medicine, University of Kentucky College of Medicine
Update on the Diagnosis and Monitoring of HIV-1 Infection 20
Angela Darko, MD,
1
William Kabat, BS,
2
Niel Constantine, PhD
1,4
and Richard Y Zhao, PhD
1,3,4
1. Department of Pathology; 2. Chicago Children’s Memorial Hospital; 3. Department of
Microbiology-Immunology; 4. Institute of Human Virology, University of Maryland School of Medicine
The Continuing Spread of HIV/AIDS in the Southern US 24
Han-Zhu Qian, MD, PhD
1
and Sten H Vermund, MD, PhD
2
1. Assistant Professor of Medicine and
Core Scholar; 2. Professor of Medicine and Director, Institute for Global Health, Vanderbilt University
School of Medicine
HIV-1 and Herpes Simplex Virus Type 2—A Dastardly Duo
WWW
Ryan King and Harvey M Friedman, MD Infectious Disease Division, Department of Medicine,
University of Pennsylvania School of Medicine
Viral Infections
Treatment of Chronic Hepatitis B—When to Start,
When to Stop, and When to Alter Therapy 28
Emmet B Keeffe, MD, MACP Division of Gastroenterology and Hepatology, Department of Medicine,
Stanford University School of Medicine
Medical Options in the Event of an Influenza Pandemic 31
John H Beigel, MD Staff Clinician, National Institute of Allergy and Infectious Diseases,
National Institutes of Health
Parainfluenza Viruses—New Epidemiology and Vaccine Developments
WWW
Stephen B Greenberg, MD, FACP
1
and Robert L Atmar, MD, FACP
2
1. Professor of Medicine and
Dean of Medical Education; 2. Professor of Medicine and Molecular Virology & Microbiology,
Baylor College of Medicine, Houston, Texas
2 US INFECTIOUS DISEASE 2007
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68